Brii Biosciences Limited (BRIBF)
OTCMKTS
· Delayed Price · Currency is USD
0.126
0.00 (0.00%)
At close: Jul 8, 2024
Brii Biosciences Employees
Brii Biosciences had 128 employees as of December 31, 2023. The number of employees decreased by 18 or -12.33% compared to the previous year.
Employees
128
Change (1Y)
-18
Growth (1Y)
-12.33%
Revenue / Employee
$55,595
Profits / Employee
-$384,508
Market Cap
107.05M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 128 | -18 | -12.33% |
Dec 31, 2022 | 146 | 33 | 29.20% |
Dec 31, 2021 | 113 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
Brii Biosciences News
- 15 days ago - Brii Bio Announces Signing of Asset Purchase Agreements Acquiring BRII-179 IP Rights and Completed Patient Enrollment for ENRICH Study - PRNewsWire
- 2 months ago - Brii Bio Delivers First Head-to-Head Comparison of siRNA (Elebsiran) and PEG-IFNα Combination versus PEG-IFNα Alone at AASLD's The Liver Meeting® 2024, Demonstrating Higher Loss of HBV Surface Antigen by Combining with siRNA - PRNewsWire
- 7 months ago - Brii Bio Presents New Data from Its Ongoing Phase 2 Chronic Hepatitis B Trials at EASL™ Congress 2024 - PRNewsWire
- 1 year ago - Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer - PRNewsWire
- 1 year ago - Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023 - PRNewsWire
- 1 year ago - Brii Biosciences Provides Latest Clinical Development and Corporate Updates - PRNewsWire
- 1 year ago - Brii Biosciences Announces Entry into Definitive Agreements from Sale of its Equity Interest in Qpex Biopharma and Acquiring Exclusive Global Rights for BRII-693 - PRNewsWire
- 1 year ago - Brii Biosciences Announces First Subject Dosed in Phase 1 Clinical Trial of BRII-297, Long-Acting Injectable for the Treatment of Anxiety and Depressive Disorders - PRNewsWire